Terumo

Terumo OCF Margin

The Operating Cash Flow Margin of Terumo (4543.T) as of Oct 21, 2026 is 20.40 %. In the previous year, Operating Cash Flow Margin was 20.34 % — a change of 0.25% (higher).

OCF Margin

20.40 %

YoY

0.25%

Last updated:

Operating Cash Flow Margin of Terumo is 2026 20.40 % . Operating Cash Flow Margin of Terumo was 2025 20.34 % . It decreases by 0.25% higher compared to the previous year.

The Terumo OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2019
15.61 JPY
Jan 1, 2020
18.68 JPY
Jan 1, 2021
19.79 JPY
Jan 1, 2022
20.11 JPY
Jan 1, 2023
14.33 JPY
Jan 1, 2024
15.87 JPY
Jan 1, 2025
20.34 JPY
Jan 1, 2026
20.40 JPY
The Terumo OCF Margin history
YEAROCF MarginYoY
20.40 %+0.25%
20.34 %+28.17%
15.87 %+10.77%
14.33 %-28.76%
20.11 %+1.64%
19.79 %+5.95%
18.68 %+19.68%
15.61 %-19.92%
19.49 %+23.93%
15.73 %+2.82%
15.30 %+2.41%
14.94 %-27.48%
20.60 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Terumo Stock analysis

What does Terumo do? Terumo Corporation is a Japanese company that was founded in 1921. The company is headquartered in Tokyo and specializes in the development, manufacturing, and marketing of medical products and devices. It has a global presence and employs approximately 28,000 people in over 160 countries. The company's history began with the establishment of a small medical device company called Sekisen Kenonsha, founded by a group of doctors. In 1942, the company merged with another company named Terumo Sougou Kenkyuusho and became Terumo Corporation. Since then, the company has continuously expanded and diversified its product range. Terumo's business model focuses on providing solutions to improve people's health worldwide through the development of innovative medical devices and products. The company operates in three main business areas: 1. Interventional Systems: This business area specializes in the development of catheters, stent systems, and other medical products for cardiac, peripheral, and vascular interventions. 2. Blood Systems: This business area offers a wide range of products for blood collection and processing, including disposable syringes for blood collection and venous and arterial access systems. 3. Biosciences: This business area focuses on the development of products for cell culture and regenerative medicine, including stem cell therapy and cell banks for research. Terumo distributes its products not only directly to hospitals and medical facilities but also collaborates closely with distributors and partners to reach a wider customer base. Additionally, the company invests significant resources in research and development to continuously expand its product range. Among the products that Terumo offers, some of the most advanced and innovative medical devices on the market can be found. One example is the state-of-the-art catheters and stent systems that enable doctors to perform minimally invasive procedures to treat serious cardiovascular diseases. Terumo also produces disposable syringes that are widely used due to their high quality and reliability. In recent years, Terumo has also invested in regenerative medicine by developing products for cell culture and therapy. This includes stem cell therapy products that can be used in the treatment of certain cancers and blood disorders. Overall, Terumo Corporation has a long history as one of the leading companies in the medical technology industry. With its innovative products and strong focus on research and development, the company will continue to play an important role in improving the health and well-being of people worldwide. Terumo is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Terumo stock

Operating Cash Flow Margin of Terumo is 20.40 % in 2026.

Operating Cash Flow Margin of Terumo changed from 20.34 % to 20.40 %, representing a 0.25% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Terumo since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Terumo with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Terumo

All Key Metrics — Terumo